| Up |
BP |
GO:0006955 ∼immune response |
82 |
1.68E–27 |
|
|
GO:0006954 ∼inflammatory response |
65 |
4.94E–18 |
|
|
GO:0060333 ∼interferon-gamma-mediated signaling pathway |
25 |
1.81E–12 |
|
|
GO:0050776 ∼regulation of immune response |
37 |
1.17E–11 |
|
|
GO:0051607 ∼defense response to virus |
31 |
1.68 E–27 |
|
CC |
GO:0009897 ∼external side of plasma membrane |
40 |
1.37 E–11 |
|
|
GO:0005886 ∼plasma membrane |
267 |
4.06 E–11 |
|
|
GO:0009986 ∼cell surface |
66 |
5.70 E–11 |
|
|
GO:0005887 ∼integral component of plasma membrane |
118 |
2.64 E–09 |
|
|
GO:0005615 ∼extracellular space |
107 |
6.10 E–07 |
|
MF |
GO:0004872 ∼receptor activity |
32 |
5.21 E–06 |
|
|
GO:0005102 ∼receptor binding |
42 |
9.04 E–06 |
|
|
GO:0042605 ∼peptide antigen binding |
12 |
1.35 E–05 |
|
|
GO:0005201 ∼extracellular matrix structural constituent |
14 |
6.51 E–03 |
|
|
GO:0005515 ∼protein binding |
431 |
2.13 E–02 |
|
PATHWAY |
hsa04145:Phagosome |
37 |
5.57 E–12 |
|
|
hsa05416:Viral myocarditis |
23 |
3.25 E–11 |
|
|
hsa05330:Allograft rejection |
19 |
5.75 E–11 |
|
|
hsa05332:Graft-versus-host disease |
18 |
8.75 E–11 |
|
|
hsa05150:Staphylococcus aureus infection |
22 |
1.07 E–10 |
| Down |
BP |
GO:0055114 ∼oxidation–reduction process |
56 |
1.02 E–09 |
|
|
GO:0006814∼sodium ion transport |
16 |
5.11 E–05 |
|
|
GO:0007588 ∼excretion |
11 |
2.49 E–04 |
|
|
GO:0055078 ∼sodium ion homeostasis |
7 |
6.67 E–04 |
|
|
GO:0001657 ∼ureteric bud development |
10 |
3.58 E–03 |
|
CC |
GO:0070062 ∼extracellular exosome |
215 |
7.05 E–38 |
|
|
GO:0016324 ∼apical plasma membrane |
44 |
9.64 E–15 |
|
|
GO:0016323 ∼basolateral plasma membrane |
31 |
4.53 E–11 |
|
|
GO:0005759 ∼mitochondrial matrix |
38 |
1.05E–08 |
|
|
GO:0005782 ∼peroxisomal matrix |
11 |
0.001373 |
|
MF |
GO:0003824 ∼catalytic activity |
23 |
1.23E–04 |
|
|
GO:0009055 ∼electron carrier activity |
16 |
1.42E–04 |
|
|
GO:0050660 ∼flavin adenine dinucleotide binding |
13 |
7.38E–04 |
|
|
GO:0016491 ∼oxidoreductase activity |
22 |
1.50E–03 |
|
|
GO:0030170 ∼pyridoxal phosphate binding |
12 |
1.64E–03 |
|
PATHWAY |
hsa01100:Metabolic pathways |
111 |
3.54E–16 |
|
|
hsa01130:Biosynthesis of antibiotics |
31 |
1.14E–06 |
|
|
hsa00280:Valine, leucine and isoleucine degradation |
13 |
2.41E–04 |
|
|
hsa01200:Carbon metabolism |
18 |
2.50E–03 |
|
|
hsa00071:Fatty acid degradation |
11 |
5.18E–03 |
